Quest Diagnostics Inc

DGXNEW YORK STOCK EXCHANGE, INC.

Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information, and services. The company is headquartered in Secaucus, New Jersey and currently employs 45,000 full-time employees. The firm provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. The company operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. The company offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. The company also focuses on artificial intelligence (AI) and digital pathology solutions. The Company’s services primarily are provided under the Quest Diagnostics brand and under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.

Latest news, analyst ratings, earnings reports, dividends, insider trades, and market analysis for Quest Diagnostics Inc.